Page last updated: 2024-08-26

bosentan anhydrous and Uveitis

bosentan anhydrous has been researched along with Uveitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bağrıaçık, EÜ; Dileköz, E; Ercan, S; Karaca, EE; Kul, O; Or, M; Öztürk Fincan, GS; Uzun, F1
Akpinar, E; Altuner, D; Atmaca, HT; Bayraktutan, Z; Cakici, O; Ekinci, M; Halici, Z; Keles, S; Yayla, M; Yildirim, K1

Other Studies

2 other study(ies) available for bosentan anhydrous and Uveitis

ArticleYear
The effect of endothelin receptor antagonists in the endotoxin-induced uveitis rabbit model
    Cutaneous and ocular toxicology, 2018, Volume: 37, Issue:2

    Topics: Animals; Aqueous Humor; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Eye; Eye Proteins; Intravitreal Injections; Leukocyte Count; Lipopolysaccharides; Male; Peptides, Cyclic; Rabbits; Sulfonamides; Uveitis

2018
The ocular endothelin system: a novel target for the treatment of endotoxin-induced uveitis with bosentan.
    Investigative ophthalmology & visual science, 2014, May-15, Volume: 55, Issue:6

    Topics: Animals; Aqueous Humor; Bosentan; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelin Receptor Antagonists; Endothelins; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Glucocorticoids; Male; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Endothelin; RNA; Sulfonamides; Treatment Outcome; Uveitis

2014